Recent Advances in Dengue Fever Based on Serotypes, Virulence Factors, Prevention, and Treatment: A Comprehensive Review
Disease and Diagnosis · 2025
DOI: 10.34172/ddj.1648 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease and Diagnosis, 2025. Verfasst von Ali Salimi Asl und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Dengue fever, a Flaviviridae viral disease, exhibits various clinical symptoms, such as hemorrhagic fever, and is influenced by multiple factors. This comprehensive review aims to explore different aspects of dengue fever. The morbidity of the virus is affected by its serotype, which has three structural proteins (capsid, pre-membrane, and envelope), seven nonstructural proteins, and the host’s immune system. Neutralizing antibodies are highly recommended to stop the virus replication. The most effective way to prevent the virus is to eliminate or reduce human interaction with its carriers; "Dengvaxia", a tetravalent vaccine, is also approved.
Zitieren
APA
Asl, A. S., Seddighi, N., Barani, A. M., Nasab, M. N., & Barahimi, E. (2025). Recent Advances in Dengue Fever Based on Serotypes, Virulence Factors, Prevention, and Treatment: A Comprehensive Review. Disease and Diagnosis. https://doi.org/10.34172/ddj.1648
Vancouver
Asl AS, Seddighi N, Barani AM, Nasab MN, Barahimi E. Recent Advances in Dengue Fever Based on Serotypes, Virulence Factors, Prevention, and Treatment: A Comprehensive Review. Disease and Diagnosis. 2025. doi:10.34172/ddj.1648
BibTeX
@article{Asl2025,
author = {Asl, Ali Salimi and Seddighi, Narjes and Barani, Amir Mohammad and Nasab, Mahla Naderi and Barahimi, Elham},
title = {Recent Advances in Dengue Fever Based on Serotypes, Virulence Factors, Prevention, and Treatment: A Comprehensive Review},
journal = {Disease and Diagnosis},
year = {2025},
doi = {10.34172/ddj.1648}
}
EUVIMED